Prothena Corporation PLC (NASDAQ:PRTA)

36.37
Delayed Data
As of Apr 27
 -0.98 / -2.62%
Today’s Change
16.71
Today|||52-Week Range
45.00
+75.19%
Year-to-Date
No recent news for Prothena Corporation PLC.

Today’s Trading

Previous close37.35
Today’s open37.38
Day’s range35.33 - 38.13
Volume584,660
Average volume (3 months)498,147
Market cap$1.1B
Dividend yield--
Data as of 04/27/2015

Growth & Valuation

Earnings growth (last year)+86.82%
Earnings growth (this year)--
Earnings growth (next 5 years)-134.72%
Revenue growth (last year)+7,422.78%
P/E ratioNM
Price/Sales10.07
Price/Book3.53

Competitors

 Today’s
change
Today’s
% change
RGENRepligen Corp-2.18-6.27%
PDLIPDL BioPharma Inc-0.18-2.56%
KPTIKaryopharm Therapeut...-2.03-6.45%
FOLDAmicus Therapeutics ...-1.11-9.06%
Data as of 04/27/2015

Financials

Next reporting dateMay 12, 2015
EPS forecast (this quarter)-$0.59
Annual revenue (last year)$50.9M
Annual profit (last year)-$7.2M
Net profit margin-14.06%

Profile

Sector
Health Technology
Industry
Biotechnology
President, Chief Executive Officer &
Director
Dale B. Schenk
Chief Financial Officer &
Head-Investor Relations
Tran B. Nguyen
Corporate headquarters
Dublin, Dublin

Forecasts

To view my watchlist

Not a member yet?

Sign up now for a free account

Partner Financial Offers